1141 Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer
Keiichi KontaniAndizhan State Medical Institute, Gynecology, Andijan, UzbekistanS. HashimotoKagawa University Faculty of Medicine, Department of Respiratory Breast and Ecdocrine Surgery, Kagawa, Japan,Chisa MurazawaKagawa University Faculty of Medicine, Department of Respiratory Breast and Ecdocrine Surgery, Kagawa, Japan,M. OhtaniManabu DateAkira YamauchiKitano Hospital, Department of Breast Surgery, Osaka, Japan,H. YokomiseKagawa University Faculty of Medicine, Department of Respiratoy Breast and Endocrine Surgery, Kagawa, Japan
ABI
Аннотация
Аннотация мавжуд эмас.
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос0 та фойдаланилган манба
Кўрсаткичлар — AkademScholar · Тез орада